PATENT CLAIM ANALYSIS

Application Number: 15758016
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-08
Patent Classification: ["514", "007400"]

Abstract:
Disclosed are compositions and methods for the reduction of C5a mediated immune inflammation. The methods, in various aspects, may include the step of administering a C5aR antagonist to a subject in need of such treatment. In one aspect, the subject in need may have a lysosomal acid storage disease. Therapeutic kits and articles of manufacture are also disclosed.

Claim (Index 7):
The method according to  claim 5 , wherein said reduction of C5a mediated immune inflammation is in a patient having a lysosomal storage disease selected from globoid cell leukodystrophy, GM2 gangliosidosis, Niemann-Pick C, mucopolysaccharidoses, Fabry, Tay-Sachs, Sandhoff, Hypercholesterolemia, Gaucher's Disease, and combinations thereof.

Metadata:
- Claim Count in Document: 27.0
- Percentile: 90.0
- Lexical Diversity: 1.44444
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['12920293', '13590016', '13505976', '15077256', '13720685']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7240585570884659
- 35 USC 102 Novelty (BERT): 0.5122730732292562
- Combined Prediction Score: 0.7028800087025449
- Mean Citation Score: 247.988656
- Max Citation Score: 258.13147000000004
- Similarity Product: 185.44829512241367

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test